Artelo Biosciences (ARTL) Enterprise Value Growth (1y) (2015 - 2025)
Artelo Biosciences (ARTL) Enterprise Value Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 74.34% |
| Sep 30, 2025 | 64.59% |
| Jun 30, 2025 | 63.12% |
| Mar 31, 2025 | 90.20% |
| Dec 31, 2024 | 77.58% |
| Sep 30, 2024 | -84.05% |
| Jun 30, 2024 | 2.05% |
| Mar 31, 2024 | -10.02% |
| Dec 31, 2023 | -24.37% |
| Sep 30, 2023 | 69.40% |
| Jun 30, 2023 | 52.82% |
| Mar 31, 2023 | 44.00% |
| Nov 30, 2021 | -256.81% |
| Aug 31, 2021 | -209.48% |
| May 31, 2021 | -685.79% |
| Feb 28, 2021 | -465.43% |
| Nov 30, 2020 | -118.86% |
| Aug 31, 2020 | 51.60% |
| May 31, 2020 | -54.62% |
| Feb 29, 2020 | -333.83% |